Page 52 - MI-1-1
P. 52

Microbes & Immunity                                                  The feature of bladder cancer stem cells



               dehydrogenase 1A1 in stem cells and cancer.  Oncotarget.   progression and chemoresistance of urothelial carcinoma.
               2016;7(10):11018-11032.                            Oncotarget. 2017;8(21):34362-34373.
               doi: 10.18632/oncotarget.6920                      doi: 10.18632/oncotarget.16156
                                          +
            55.  Yang W, Wang C, Lin Y, et al. OV6  tumor-initiating cells   66.  Hayashi T, Gust KM, Wyatt AW, et al. Not all NOTCH is
               contribute to tumor progression and invasion in human   created equal: The oncogenic role of NOTCH2 in bladder
               hepatocellular carcinoma. J Hepatol. 2012;57(3):613-620.  cancer and its implications for targeted therapy. Clin Cancer
                                                                  Res. 2016;22(12):2981-2992.
               doi: 10.1016/j.jhep.2012.04.024
                                                                  doi: 10.1158/1078-0432.Ccr-15-2360
            56.  Lin CH, Liu CH, Tsai HL, Wang JY, Tsai HP, Chai CY. Expression
               of OV-6 in primary colorectal cancer and rectal cancer with   67.  Yang Z, He L, Lin K,  et al. The KMT1A-GATA3-STAT3
               preoperative chemoradiotherapy: A clinicopathological study.   circuit is a novel self-renewal signaling of human bladder
               Histopathology. 2013;62(5):742-751.                cancer stem cells. Clin Cancer Res. 2017;23(21):6673-6685.
               doi: 10.1111/his.12075                             doi: 10.1158/1078-0432.Ccr-17-0882
            57.  Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC.   68.  Ma S, Meng Z, Chen R, Guan KL. The hippo pathway: Biology
               Isolation and functional properties of murine hematopoietic   and pathophysiology. Annu Rev Biochem. 2019;88:577-604.
               stem cells that are replicating  in vivo.  J  Exp Med.
               1996;183(4):1797-1806.                             doi: 10.1146/annurev-biochem-013118-111829
                                                               69.  Li X, Zhuo S, Cho YS,  et al. YAP antagonizes TEAD-
               doi: 10.1084/jem.183.4.1797
                                                                  mediated AR signaling and prostate cancer growth. EMBO
            58.  Hepburn AC, Veeratterapillay R, Williamson SC, et al. Side   J. 2023;42(4):e112184.
               population in human non-muscle invasive bladder cancer      doi: 10.15252/embj.2022112184
               enriches for cancer stem cells that are maintained by MAPK
               signalling. PLoS One. 2012;7(11):e50690.        70.  Lo Sardo F, Strano S, Blandino G. YAP and TAZ in lung
                                                                  cancer: Oncogenic role and clinical targeting.  Cancers
               doi: 10.1371/journal.pone.0050690
                                                                  (Basel). 2018;10(5):137.
            59.  Ning ZF, Huang YJ, Lin TX,  et al. Subpopulations of      doi: 10.3390/cancers10050137
               stem-like cells in side population cells from the human
               bladder transitional cell cancer cell line T24. J Int Med Res.   71.  Li X, Zhuo S, Zhuang T, et al. YAP inhibits ERα and ER(+)
               2009;37(3):621-630.                                breast cancer growth by disrupting a TEAD-ERα signaling
                                                                  axis. Nat Commun. 2022;13(1):3075.
               doi: 10.1177/147323000903700304
                                                                  doi: 10.1038/s41467-022-30831-5
            60.  She JJ, Zhang PG, Wang ZM, Gan WM, Che XM.
               Identification of side population cells from bladder cancer   72.  Birney E, Stamatoyannopoulos JA, Dutta A,  et  al.
               cells by DyeCycle Violet staining.  Cancer Biol Ther.   Identification and analysis of functional elements in 1% of
               2008;7(10):1663-1668.                              the human genome by the ENCODE pilot project. Nature.
                                                                  2007;447(7146):799-816.
               doi: 10.4161/cbt.7.10.6637
                                                                  doi: 10.1038/nature05874
            61.  Robbins DJ, Fei DL, Riobo NA. The Hedgehog signal
               transduction network. Sci Signal. 2012;5(246):re6.  73.  Lee YS, Dutta A. MicroRNAs in cancer. Annu Rev Pathol.
                                                                  2009;4:199-227.
               doi: 10.1126/scisignal.2002906
                                                                  doi: 10.1146/annurev.pathol.4.110807.092222
            62.  Barker N, Clevers H. Mining the Wnt pathway for cancer
               therapeutics. Nat Rev Drug Discov. 2006;5(12):997-1014.  74.  Li Y, Li G, Guo X, Yao H, Wang G, Li C. Non-coding RNA in
                                                                  bladder cancer. Cancer Lett. 2020;485:38-44.
               doi: 10.1038/nrd2154
                                                                  doi: 10.1016/j.canlet.2020.04.023
            63.  Brandt  WD,  Matsui  W,  Rosenberg  JE,  et al.  Urothelial
               carcinoma: Stem cells on the edge. Cancer Metastasis Rev.   75.  Hansen TB, Jensen TI, Clausen BH,  et al. Natural RNA
               2009;28(3-4):291-304.                              circles  function as  efficient  microRNA  sponges.  Nature.
                                                                  2013;495(7441):384-388.
               doi: 10.1007/s10555-009-9187-6
                                                                  doi: 10.1038/nature11993
            64.  Gu C, Wang Z, Zhou N, et al. Mettl14 inhibits bladder TIC
               self-renewal and bladder tumorigenesis through N(6)-  76.  Wilusz JE, Sharp PA. Molecular biology. A circuitous route
               methyladenosine of Notch1. Mol Cancer. 2019;18(1):168.  to noncoding RNA. Science. 2013;340(6131):440-441.
               doi: 10.1186/s12943-019-1084-1                     doi: 10.1126/science.1238522
            65.  Zhang H, Liu L, Liu C, et al. Notch3 overexpression enhances   77.  Li H, Yang J, Wei X, et al. CircFUT10 reduces proliferation


            Volume 1 Issue 1 (2024)                         46                               doi: 10.36922/mi.2377
   47   48   49   50   51   52   53   54   55   56   57